Feed PTGX
PT
Protagonist Therapeutics
PTGX · NASDAQ
$146.18 +0.81% (+$1.17)
1M +4.36%
Market Cap $9.4B
P/E Ratio -
Div. Yield -
ROE 17.76%
Bulios Fair Price
$78.63
46.2% downside
Preț actual
$146.18
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile PTGX sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
0 /100
Expensive P/S 335.19x
P/B 14.34x
P/E N/A
Growth
100 /100
Growing Rev. growth 20.07%
Book val. growth 41.80%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 98.55%
FCF margin 414.68%
Net margin 409.00%
Quality
0 /100
Poor ROIC 21.29%
Asset turnover 0.04x
ROE 17.76%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 17.76x
Int. coverage N/A
Stability
3 /100
Unstable Beta 1.79x
Profitable years 0
Rev. volatility 365.98%
Întreabă StockBot despre PTGX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Dinesh V. Patel
Employees
132
Headquarters
Newark
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report